A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Global Pharmaceutical Excipients Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.
Global Pharmaceutical Excipients Market Analysis
According to cognizance market research, the global pharmaceutical excipients market was valued at US$ 8,765.4 Million in 2022 and is anticipated to reach US$ 13,346.0 Million by the end of 2030 with a CAGR of 5.4% from 2023 to 2030.
What are Pharmaceutical Excipients?
Pharmaceutical excipients are inert substances that are used with active pharmaceutical ingredients (API) in medication formulations to simplify manufacturing, enhance drug distribution, and improve the stability, safety, and efficacy of the finished pharmaceutical product. A wide variety of compounds, including fillers, binders, lubricants, disintegrants, colouring agents, preservatives, and flavouring agents, can be used as excipients. The safety, efficacy, and compatibility of these ingredients with the API and other excipients in the formulation are carefully considered and tested. Excipient selection and use are crucial components of the development and formulation of drugs since they can significantly affect the performance and properties of a medicinal product.
Excipients used in pharmaceutical formulation and development are important. These substances contain ingredients besides the drug or prodrug that is pharmacologically active. Drug distribution to the target site is facilitated by pharmaceutical excipients. These molecules assimilate and improve the medicine’s effectiveness while preventing the drug from being released too early. Some excipients used in pharmaceuticals encourage drug integration, which increases drug absorption in the bloodstream.
Pharmaceutical Excipients Market Outlook
In the global pharmaceutical excipients market report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.
The price of a generic drug is typically 60–70% less expensive than that of a brand-name drug two–three years after the loss of exclusivity. Generic drugs, like brand-name drugs, need competition in the generic drug market before costs may be reduced. The use of generic medications has dramatically expanded nationwide in recent years. One of the main factors anticipated to fuel the expansion of the pharmaceutical sector is the availability of affordable alternatives to name-brand medications. The global pharmaceutical excipients market is thus anticipated to increase as a result of rising generic medicine demand and rising output. Additionally, because generic medications are less expensive, they are used more frequently.
Excipients play a minor role in the worldwide pharmaceutical industry’s rising development. The demand for excipients has increased in recent years as a result of rising generic medicine demand. Additionally, the prevalence of chronic diseases has dramatically increased. Excipients are frequently employed in the preparation of pharmaceuticals to increase the volume of solid formulations, offer long-term stability, and improve drug absorption. Additionally, it enhances the product’s general functionality or safety while usage or storage. The global pharmaceutical excipients market is thus anticipated to be driven by the extensive use of excipients in medication formulation and its applications.
Since mixing excipients has led to unfavourable patient outcomes, authorities and medication makers now prioritise controlling the production and distribution of excipients. Furthermore, improved control of the supply and quality of pharmaceutical excipients has become more crucial in the context of in vivo activity as a result of the development of new excipients and delivery systems. Excipient suppliers must satisfy the pharmaceutical industry’s quality standards due to the excipients’ crucial role in pharmaceutical dosage forms, and the pharmaceutical industry as a whole must work to ensure the product’s safety. The supply chain’s use or storage integrity. Therefore, it is anticipated that the expansion of the worldwide pharmaceutical excipients market will be constrained by the increasing regulatory requirements for the licencing of pharmaceuticals and excipients.
Pharmaceutical excipients in medication formulations rarely cause adverse effects, but when they do, the risk of toxicity is elevated, especially in neonates and young children. Among the common pharmaceutical excipients with known negative effects include Methyl and Propyl para-hydroxybenzoate (Parabens), Benzyl Alcohol, Sodium Benzoate, Benzoic Acid, and Propylene Glycol, among others. Excipients used in pharmaceutical products are not necessarily the neutral compounds we assume. They are either intolerant to a specific person or, if properly screened, they have the potential to chemically alter the drug, resulting in the side effect. This could have an impact on excipient demand and is anticipated to present a challenge for the worldwide excipients market for pharmaceuticals.
The pharmaceutical excipients market has been segmented into type, functionality, formulation and geography.
Based on type, the market for pharmaceutical excipients is classified into organic chemicals, inorganic chemicals and other chemicals. The organic chemicals segment has been further categorised into five categories viz. carbohydrates, petrochemicals, oleochemicals, proteins and other organic chemicals. Because more organic compounds are being used in various pharmaceutical formulations, the organic segment is predicted to dominate the market.
Based on functionality, the pharmaceutical excipients market has been bifurcated into fillers & diluents, suspending & viscosity agents, coating agents, binders, flavouring agents & sweeteners, disintegrants, colourants, lubricants & glidants, preservatives, buffers, sorbent, emollients, chelating agents, antifoaming agents, emulsifying agents and others. Due to the rising demand for pharmaceutical and biopharmaceutical drugs as well as the introduction of new products, the binders category is anticipated to have considerable expansion throughout the forecast period.
Based on formulation, the pharmaceutical excipients market is segmented into topical formulations. oral formulations. parenteral formulations and others. The largest market share belongs to oral formulation. Oral drug administration keeps the drugs’ chemical and physical stability while assisting the manufacturer with packaging and transportation.
Based on geography the global pharmaceutical excipients market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
Europe held the largest market share for pharmaceutical excipients, and it is anticipated that it would continue to dominate the market during the projected period. Due to the imminent expiration of drug patents, many European nations are concentrating on the generics industry. As a result, considerable growth rates in European nations like Germany, the United Kingdom, France, and others are predicted to occur throughout the projection period. This is projected to increase demand for pharmaceutical excipients in the region. Additionally, it is projected that the market for generic medications in these nations will be driven by the expanding government initiatives for lowering the prices of the drugs on the market. The aforementioned elements are projected to enhance the demand for new excipients, which will help the pharmaceutical excipients market in Europe grow along with increased investments in the development of biologics and innovative dosage forms.
Due to the rising demand for potent oral medications for the treatment of chronic disorders, the North American market is anticipated to expand at a substantial rate over the course of the projected period. However, the Asia-Pacific region is predicted to have the highest CAGR due to the availability of cheap labour and low-cost raw resources.
The report offers the revenue of the global pharmaceutical excipients market for the period 2020-2030, considering 2020 & 2021 as a historical years, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global pharmaceutical excipients market for the forecast period. The global pharmaceutical excipients market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global pharmaceutical excipients market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the pharmaceutical excipients market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global pharmaceutical excipients market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have been also studied to understand the global pharmaceutical excipients market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global pharmaceutical excipients market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the pharmaceutical excipients market. The subsequent section of the global pharmaceutical excipients report highlights the USPs, which include key industry events (product launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Global Pharmaceutical Excipients Market Competitive Landscape
The “Global Pharmaceutical Excipients Market” study report will provide valuable insight with an emphasis on the global market including some of the significant players such as-
Key developments in the pharmaceutical excipients market-
The report explores the competitive scenario of the global pharmaceutical excipients market. Major players operating in the pharmaceutical excipients market have been identified and profiled for unique commercial attributes. Company overview (company description, product portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the pharmaceutical excipients market report.
Global Pharmaceutical Excipients Market, By Type
Global Pharmaceutical Excipients Market, by Functionality
Global Pharmaceutical Excipients Market, by Formulation
Global Pharmaceutical Excipients Market, by Region
Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, and Chemie Trade are some of the major players operating in the market.
Pharmaceutical excipients are inert substances that are used with active pharmaceutical ingredients (API) in medication formulations to simplify manufacturing, enhance drug distribution, and improve the stability, safety, and efficacy of the finished pharmaceutical product
In terms of formulation, the oral formulation segment dominated the market because oral drug administration keeps the drugs’ chemical and physical stability while assisting the manufacturer with packaging and transportation.
Based on functionality, the binders sector is expected to dominate the market Due to the rising demand for pharmaceutical and biopharmaceutical drugs as well as the introduction of new products
Europe is the leading country in the pharmaceutical excipients market.
Get insights that lead to new growth opportunities
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail